MiniMed Group Inc

NASDAQ • Healthcare • Medical Instruments & Supplies • Quote as of 10/23/2026

Company Profile

IndustryMedical Instruments & Supplies

SectorHealthcare

ExchangeNASDAQ

Market Capitalization5,145.89 mln

Float27.17 mln

Earnings Date06/09/2027

1-Year Forecast

25.47

Strong upside

Relative Strength

37 / 100

Underperforming

Debt / Equity

0.02

Debt-free

Pre-Tax Margin

-7%

Marginally loss-making

ROE

-9.01

Negative

Altman Z-Score

3.75

Strong

Business Description

Minimed Group Inc. is a California-based medical technology company founded in 1983 that creates and sells tools to help people with diabetes manage their insulin therapy. Its product range includes insulin pumps, pens, continuous glucose monitors, and supporting software, serving both Type 1 and insulin-dependent Type 2 diabetes patients. Since March 2026, the company has operated independently, having separated from Medtronic Global Holdings.

Key Fundamentals

EPS-1.53

ROE-9.01

RPS12.22

ROIC7.31

ROA-7.03

EBITDA, mln-66.00

EV / EBITDA-81.08

EV / EBIT-28.93

Revenue, mln2,470

EV / Revenue2.17

Quote Details

Last 18.34

Change 0.05 (0.27%)

Open 18.47

Volume 4,785,410

Turnover 87,764,424

Average Volume 16,498,920

Financial Ratios

Pre-Tax Profit Margin-7

Leverage Ratio1.30

Current Ratio1.81

Price / Book1.52

Price / Tangible Book4.35

Debt / Equity0.02

Price / Sales2.29

Financial Strength

Altman Z-Score3.75

1-Year Target Price25.47

Short Ratio6.07

Short % of Float63.77

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	4.86%	83 / 100
1 Month	-10.27%	38 / 100
2 Months	8.39%	74 / 100
6 Months	38.94%	90 / 100